Hotline - TAVI - Part 1

Anchorperson: N. Dumonteil

Spokesperson: J. Popma

Summary

This comprehensive session examines the latest evidence and clinical trial data on TAVI, including comparisons of balloon-expandable versus self-expanding valves in failed bioprostheses, techniques to reduce coronary obstruction risk, and real-world outcomes across diverse populations. Cost-effectiveness analyses and longitudinal studies further inform best practices for optimizing TAVI strategies.

Presentations available when logged in:

Balloon vs. self-expanding valves in failed small aortic bioprostheses: three-year follow-up LYTEN trial
Latest-iteration balloon-expandable vs. self-expanding valves in failed surgical prosthesis
Leaflet modification techniques to mitigate coronary obstruction risk: the LOFTER-TAVI registry
BASILICA in native vs. valve-in-valve procedures: insights from the LOFTER-TAVI registry
Progression and outcomes of mild to moderate aortic stenosis: insights from the GUARD study
Real-world outcomes of TAVI in China: one-year follow-up of the multicentre CARRY II study
Cost effectiveness of early TAVI for asymptomatic severe aortic stenosis across nine European countries

Your free My PCR account will enable you to:

Become a PCR Companion
Access slide presentations from PCR Courses
Watch session videos and LIVE cases
Discuss cases with your peers
Submit and register for PCR Courses
Register for and view PCR Webinars
Read a selection of articles in EuroIntervention
And more…

Hotline - TAVI - Part 1

Log in or create account for free